| Palm oil delights
Studies show palm tocotrienols inhibit the growth of skin, stomach, pancreas, liver, lung, colon, prostate, breast and other cancers. Most of the research to date has been done with breast cancer where tocotrienols show great promise. They not only prevent cancer from taking hold, but actively block its growth and initiate apoptosis- a process where diseased cells commit suicide. This is a normal process that is programmed into all of our cells in order to remove old and diseased cells. However, in cancer cells this process is blocked and affected cells continue to multiply and grow without restraint. Ordinary vitamin E does not induce programmed cell death in cancer cells. Only tocotrienols have this effect. The antioxidant power of palm oil has also shown to be of benefit in protecting against neurological degeneration.
NATION IN BRIEF: Solis confirmed for Labor
For the first time, leading medical groups are advising millions of healthy men who are regularly screened for prostate cancer to consider taking a drug to prevent it. The advice stops short of saying men should take the drug finasteride, sold in generic form and as Proscar. It has not been widely prescribed as a cancer preventive, and may carry some risks. The new advice tells men to talk to their doctors and decide for themselves if the good outweighs the bad. The findings were published in two medical journals and discussed in a news briefing in connection with a cancer conference in Florida. They were written by doctors with American Society of Clinical Oncology and the American Urological Association. Copter crash kills 1, injures 1 Authorities said one person is dead and a second seriously injured following a helicopter crash on the North Carolina campus of the private security contractor Xe, about 30 minutes south of Norfolk, Va.
Ask Your Doctor
Because of our bodies' resistance and reserves, we don't usually feel full-blown symptoms unless the disease is already far-advanced, in which case it may already be beyond treatment. In the same way that we take care of our clothes, our homes and our cars, let's take care of the only temple that has been entrusted to us – our bodies. But unlike our clothes, our homes and our cars, our bodies are irreplaceable. Any lump or mass. Always make it a habit to feel your body for any lumps. You can do this when you're soaping up while taking a bath. Women, especially those who are 30 years or older, must do self-breast examination at least once a month. You are the best person to know if an unusual mass has grown. A breast lump is the first sign of breast cancer.
Online medical symptom checkers examined
And then they're looking at it and getting 16 different options and wondering why we're not ruling out various pelvic pathologies like ovarian cancer.' It's not uncommon to see one or two patients a week with such printouts, she said. Patients coming in armed with information from the symptom checker sites are fewer, she said, averaging perhaps one or two a month. She agreed with the Microsoft report that Web searches tend to escalate patients' fears. 'Absolutely, just like when we were all in medical school, we all felt we had each thing that we learned about. It is human nature. 'It does make it a little bit more difficult as a physician. Once again not that it's more difficult for us to figure out what's going on, but then we have to deal with the misconceptions that the person walked through the door with.' Dr.
UK’s first double high-dose cancer treatment delivered in Bristol
Patients are normally suffering from locally-advanced prostate cancer and receive brachytherapy as a boost prior to receiving a full course of external beam radiotherapy. Bristol Oncology Centre, which serves 2.4 million people in the Avon, Somerset and Wiltshire region, has been using a Varian GammaMed afterloader since 2005. The device is used in combination with BrachyVision treatment planning software, which enables clinicians to plan treatments by combining and using MRI, CT and 3D scans for the best possible images of the tumor and surrounding organs. .
Gov. Perry Announces $5.5 Million Research Grant to University of
Initial research has shown that estrogen receptor drugs have potential applications for treatment of breast and uterine cancer in women and prostate cancer in men. Studies have also shown that other nuclear hormone receptors can be used to treat atherosclerosis, type 2 diabetes, Parkinson's disease, Lou Gehrig's disease and depression. The center will work to commercialize this research.The ETF is a $200 million initiative created by the Texas Legislature in 2005 at the governor's request and was reauthorized in 2007. A 17-member advisory committee of high-tech leaders, entrepreneurs and research experts reviews potential projects and recommends funding allocations to the governor, lieutenant governor and speaker of the house. To date, the ETF has allocated $56 million in funds to 16 universities, attracting more than 40 top researchers and their teams to the state and creating more than $69 million of industry capital investment.For more information on the ETF, please visit www.emergingtechfund.com.
Supplement Could Cut Prostate Cancer Risk
New lab evidence suggests a preventive effect of DHEA in prostate cancer. DHEA is a steroid hormone produced by the body's adrenal glands. Some men take it as an over-the-counter supplement because it has been suggested DHEA can reverse aging. Researchers at the National Center for Complementary and Alternative Medicine (NCCAM) found a way to manipulate DHEA levels in cells in order to understand its effects. .
Alex Rodriguez: Jackpot!
The Rolling Stones rake in $75 million on their latest Swollen Prostate Tour and no one sermonizes about cancer-research funding, but let Alex Rodriguez earn a deal that vaults his annual salary up there with such living saints as Celine Dion and Tom Cruise, and baseball has been stained beyond redemption. He doesn't wear makeup or croon, but A-Rod is no less an entertainer. Fans pay to see him play -- the Rangers' advance ticket sales for the 2001 season are expected to reach nearly two million -- he plays on TV, and he does all his own stunts. Plus, he risks his livelihood each time he takes the field. No pre-free-agency baseball star ever got paid close to what he was worth, in dollars and cents, to his team or his sport. Thanks to Scott Boras, A-Rod will. Not that the men who run baseball know or care what a jewel like Alex Rodriguez might be worth in terms of attracting young and unwhite fans and all the future stars now shooting hoops and catching passes.
"Early detection of cancer saves lives."
Consider the case of prostate cancer. Although the prevalence of clinically apparent prostate cancer in men 60 to 70 years of age is only about 1 percent, over 40 percent of men in their 60s with normal rectal examinations have been found to have histologic evidence of the disease. Consequently, because the prostate is studied increasingly by transrectal ultrasonography and MRI, which can detect tumors too small to palpate, the reported prevalence of prostate cancer increases. In addition, the increased detection afforded by imaging can confuse the evaluation of therapeutic effectiveness. As the spectrum of detected prostate cancer becomes broader with the addition of tumors too small to palpate, the reported survival from the time of diagnosis improves regardless of the actual effect of the new tests and treatments.
BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)
The results from the studies support the further investigation in patients suffering from advanced prostate cancer. The abstracts can be seen in full at ASCO's website: http://www.asco.org. Study I (Abstract no. 108) Study title: "A Phase II study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM with GM-CSF in Patients with PSA Progression After Local Therapy for Prostate Cancer." In a study run by the Eastern Cooperative Oncology Group, the effect of PROSTVAC(TM) vaccination in patients with early stage recurrent prostate cancer was evaluated. Results from the study demonstrate that by using PROSTVAC(TM) in an earlier disease setting, the vaccine has the ability to decrease the rate of rise in PSA levels indicating a potential delay in disease progression.
|
